Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Reddy's S.r.l., operating as Reddy Pharma Italia, is the Italian subsidiary of the global pharmaceutical company Dr. Reddy's Laboratories. The company specializes in the commercialization of a wide range of high-quality generic medicines, biosimilars, and specialty pharmaceutical products within the Italian market. Its portfolio spans several critical therapeutic areas, including oncology, cardiology, gastroenterology, and pain management. By leveraging the extensive global research and manufacturing infrastructure of its parent organization, Reddy Pharma Italia provides cost-effective treatment options to both hospital and retail sectors. The company is committed to improving patient access to essential medicines through a robust supply chain and strategic local partnerships. As a key player in the European generic market, it continues to expand its biosimilar pipeline to address complex chronic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reddy Pharma Italia.